Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes. Flume PA, VanDevanter DR. Eur Respir J 2020;55.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Flume PA, VanDevanter DR. Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes. Eur Respir J 2020;55.
PMID: 32245773